Haatch Announces Fourth Exit of 2025

By
Jonathan Keeling
By
Haatch

We are pleased to share that Haatch has successfully exited our position in Tangible Markets, marking our fourth exit of 2025. This follows previous exits this year from Re-Flow (6.55x), Native (7.4x) and CareLineLive.

This transaction was completed via a secondary sale, as part of a wider strategic investment agreement with a new backer. The exit delivered a 42.59% IRR for our investors. 

A Milestone Moment

This marks an important milestone for Haatch. It is our second SEIS exit this year and our first exit for the British Business Bank (BBB). The BBB has been co-investing with us since 2021, supporting every deal we do. We are proud to already be delivering realised returns for such a highly valued partner and look forward to building further on this relationship.

The Bigger Picture

2025 has already been a remarkable year for Haatch with four exits across our SEIS, EIS, and BBB strategies. We are not aware of another fund in our category delivering this level of performance.

With multiple funds now showing realised returns and a growing number of portfolio companies scaling at pace, we are excited by what the rest of 2025 will bring, and beyond!

By
Jonathan Keeling
Partner
News & Updates

The latest
‍from Haatch

See More

The AI apocalypse is happening upstairs. We work downstairs.

By
Jonathan Keeling
By
Haatch
November 6, 2026
Read more
​

AI is either about to crash the stock market or put every software company out of business, depending on the headline. Haatch Partner Jeremy Luzinda pulls the two apocalypse stories apart and explains why the drama is upstairs, while the work is down here.

​

Crediflow AI raises £1.5m to scale AI-native infrastructure for commercial credit

By
Jordan Smith
By
Haatch
November 4, 2026
Read more
​

Haatch portfolio company Crediflow AI has secured £1.5m in a round led by PXN Ventures via NPIF II, with participation from Haatch and angel investors, to automate the manual work that slows down commercial lending.

​

Virtual Science AI launches Medical Competitor AI

By
Jordan Smith
By
Haatch
October 26, 2026
Read more
​

Haatch portfolio company Virtual Science AI has launched Medical Competitor AI, its fourth product, bringing real-time competitive intelligence to pharma medical affairs teams.

​

Judged by our returns, not our size

By
Jonathan Keeling
By
Haatch
October 12, 2026
Read more
​

Why Haatch built a business beyond fundraising for fees, and why that matters for investor returns.

​